REDHILL BIOPHARMA LTD
Market Data Charts Historical Prices Statistics Profile Analysis & Rating Disclosures
www.redhillbio.com
LATE CLINICAL-STAGE DEVELOPMENT AND COMMERCIALIZAION OF DRUGS FOR GASTROINTESTINAL DISEASES.
   Issuer No.   
Corporate No.
   Market Cap (19/06/2019)   
   1573   
   514304005   
    725,955 NIS thousands   
   TASE Supersector
   TASE Sector   
   TASE Subsector   
   Indices   
   High-Tech   
   Biomed   
   Biotechnology   
   TA-90, TA-125, TA-Biomed Index, TA Global-BlueTech, TA-AllShare, TA Tech - Elite, TA-Rimon, TA-SME150, TA-Industrials, Additional Indices   
Shares Bonds Convertible Bonds Warrants All Securities
  REDHILL  
 
Symbol:
RDHLDual-Listed Company Market Maker Appointed for Security  
ISIN: IL0011223810
Security Type : Share
 
Tel-Aviv 19/06/2019
 Closing Price (0.01 NIS)
 255.90 
 Change(%) -2.25% 
 Turnover (NIS)
 245,677 
 Trans.
 103 
 Capital Listed for Trading
 283,686,908 
 Market Cap (NIS thousands)
 725,955 
 Base Price
 261.80 
 Opening Price
 262.70 
 High
 263 
 Low
 255.30 
 Yield MTD (%) -4.2% 
 Yield YTD (%) 26.9% 
 Foreign Stock Exchange NASDAQ-GM 
 
 
 
Previous Trading Days - REDHIL BIOPHARM
DateClosing Price (0.01 NIS)Adjusted Closing Price*Change (%)Base PriceOpening PriceHighLowTurnover (NIS)
19/06/2019
255.90
255.90
-2.25%
261.80
262.70
263
255.30
245,677
18/06/2019
261.80
261.80
3.64%
252.60
252.60
263.80
250.10
4,039,787
   Open in a Separate Window   
* Adjusted to Dividends and Benefits
Company Disclosures - As of date 6/20/2019 - 7:43 AM Financial Statements
6/16/2019 6:44 PM
6/16/2019 6:43 PM
6/10/2019 2:59 PM
5/28/2019 1:59 PM
5/23/2019 3:01 PM
Recent Company Disclosure (Hebrew Only)
Corporate Actions